|
|
Previous Article | Table of Contents | Next Article 
The insulin receptor substrate-1-related 4PS substrate but not the
interleukin-2R gamma chain is involved in interleukin-13-mediated signal
transduction
LM Wang, P Michieli, WR Lie, F Liu, CC Lee, A Minty, XJ Sun, A Levine, MF White and JH Pierce
Laboratory of Cellular and Molecular Biology, National Institutes of
Health, Bethesda, MD 20892-4255, USA.
Interleukin-13 (IL-13) induced a potent mitogenic response in IL-3-
dependent TF-1 cells and DNA synthesis to a lesser extent in MO7E and
FDC-P1 cells. IL-13 stimulation of these lines, like IL-4 and insulin- like
growth factor-1 (IGF-1), resulted in tyrosine phosphorylation of a 170-kD
substrate. The tyrosine-phosphorylated 170-kD substrate strongly associated
with the 85-kD subunit of phosphoinositol-3 (PI-3) kinase and with Grb-2.
Anti-4PS serum readily detected the 170-kD substrate in lysates from both
TF-1 and FDC-P1 cells stimulated with IL-13 or IL-4. These data provide
evidence that IL-13 induces tyrosine phosphorylation of the 4PS substrate,
providing an essential interface between the IL- 13 receptor and signaling
molecules containing SH2 domains. IL-13 and IL-4 stimulation of murine L
cell fibroblasts, which endogenously express the IL-4 receptor (IL-4R
alpha) and lack expression of the IL-2 receptor gamma subunit (IL-2R
gamma), resulted in tyrosine phosphorylation of insulin receptor
substrate-1 (IRS-1)/4PS. Enhanced tyrosine phosphorylation of IRS-1/4PS was
observed in response to IL-4, but not IL-13 treatment of L cells
transfected with the IL-2R gamma chain. These results indicate that IL-13
does not use the IL-2R gamma subunit in its receptor complex and that
expression of IL-2R gamma enhances, but is not absolutely required for
mediating IL-4-induced tyrosine phosphorylation of IRS-1/4PS.
Volume 86,
Issue 11,
pp. 4218-4227,
12/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Khodoun, C. Lewis, J.-Q. Yang, T. Orekov, C. Potter, T. Wynn, M. Mentink-Kane, G. K. Khurana Hershey, M. Wills-Karp, and F. D. Finkelman
Differences in Expression, Affinity, and Function of Soluble (s)IL-4R{alpha} and sIL-13R{alpha}2 Suggest Opposite Effects on Allergic Responses
J. Immunol.,
November 15, 2007;
179(10):
6429 - 6438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Finkelman, M. Yang, C. Perkins, K. Schleifer, A. Sproles, J. Santeliz, J. A. Bernstein, M. E. Rothenberg, S. C. Morris, and M. Wills-Karp
Suppressive Effect of IL-4 on IL-13-Induced Genes in Mouse Lung
J. Immunol.,
April 15, 2005;
174(8):
4630 - 4638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. DiFalco, S. Ali, and L. F. Congote
The improved survival of hematopoietic cells cultured with a fusion protein of insulin-like growth factor II (IGF-II) and interleukin 3 (IL-3) is associated with increases in Bcl-xL and phosphatidylinositol-3 kinase activity
J. Leukoc. Biol.,
February 1, 2003;
73(2):
297 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jiang, K. Foltenyi, M. Kashiwada, L. Donahue, B. Vuong, B. Hehn, and P. Rothman
Fes Mediates the IL-4 Activation of Insulin Receptor Substrate-2 and Cellular Proliferation
J. Immunol.,
February 15, 2001;
166(4):
2627 - 2634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hyun, A. Yam, S. Pece, X. Xie, J. Zhang, T. Miki, J. S. Gutkind, and W. Li
Loss of PTEN expression leading to high Akt activation in human multiple myelomas
Blood,
November 15, 2000;
96(10):
3560 - 3568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. V. Chaika, N. Chaika, D. J. Volle, H. Hayashi, Y. Ebina, L.-M. Wang, J. H. Pierce, and R. E. Lewis
Mutation of Tyrosine 960 within the Insulin Receptor Juxtamembrane Domain Impairs Glucose Transport but Does Not Inhibit Ligand-mediated Phosphorylation of Insulin Receptor Substrate-2 in 3T3-L1 Adipocytes
J. Biol. Chem.,
April 23, 1999;
274(17):
12075 - 12080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Richards, M. P. Walker, J. Sebastian, and R. P. DiAugustine
Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the Uterus. ALTERED SIGNALING RESPONSE TO ESTRADIOL IN THE IGF-1m/m MOUSE
J. Biol. Chem.,
May 8, 1998;
273(19):
11962 - 11969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uddin, E. N. Fish, D. Sher, C. Gardziola, O. R. Colamonici, M. Kellum, P. M. Pitha, M. F. White, and L. C. Platanias
The IRS-Pathway Operates Distinctively From the Stat-Pathway in Hematopoietic Cells and Transduces Common and Distinct Signals During Engagement of the Insulin or Interferon-alpha Receptors
Blood,
October 1, 1997;
90(7):
2574 - 2582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Welham, H. Bone, M. Levings, L. Learmonth, L.-M. Wang, K. B. Leslie, J. H. Pierce, and J. W. Schrader
Insulin Receptor Substrate-2 Is the Major 170-kDa Protein Phosphorylated on Tyrosine in Response to Cytokines in Murine Lymphohemopoietic Cells
J. Biol. Chem.,
January 10, 1997;
272(2):
1377 - 1381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yenush, K. J. Makati, J. Smith-Hall, O. Ishibashi, M. G. Myers Jr., and M. F. White
The Pleckstrin Homology Domain Is the Principle Link between the Insulin Receptor and IRS-1
J. Biol. Chem.,
September 27, 1996;
271(39):
24300 - 24306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Caput, P. Laurent, M. Kaghad, J.-M. Lelias, S. Lefort, N. Vita, and P. Ferrara
Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor alpha Chain
J. Biol. Chem.,
July 12, 1996;
271(28):
16921 - 16926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Platanias, S. Uddin, A. Yetter, X.-J. Sun, and M. F. White
The Type I Interferon Receptor Mediates Tyrosine Phosphorylation of Insulin Receptor Substrate 2
J. Biol. Chem.,
January 5, 1996;
271(1):
278 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|